Editor's Choice - Efficacy and Safety of the New Oral Anticoagulants Dabigatran, Rivaroxaban, Apixaban, and Edoxaban in the Treatment and Secondary Prevention of Venous Thromboembolism: A Systematic Review and Meta-analysis of Phase III Trials [PDF]
, 2014 Stavros K. Kakkos +2 more
openalex +1 more source
Reversal of rivaroxaban-induced anticoagulation with prothrombin complex concentrate, activated prothrombin complex concentrate and recombinant activated factor VII in vitro [PDF]
, 2014 Elisabeth Perzborn +3 more
openalex +1 more source
Recurrence of Lemierre's Syndrome Presenting With Extensive Cerebral Venous Sinus Thrombosis: A Case Report. [PDF]
CureusTun SL, Han T, Moe AT, May I.
europepmc +1 more source
XALIA: rationale and design of a non-interventional study of rivaroxaban compared with standard therapy for initial and long-term anticoagulation in deep vein thrombosis [PDF]
, 2014 Walter Ageno +6 more
openalex +1 more source
A Novel Synthesis of the Oxazolidinone Antithrombotic Agent Rivaroxaban [PDF]
, 2014 Jianyong Yuan +5 more
openalex +1 more source
Endovenous Laser Ablation of Insufficient Superficial Veins in Patients After Deep Vein Thrombosis Recanalisation. [PDF]
Cardiovasc TherBabic S +7 more
europepmc +1 more source
Rivaroxaban in secondary prevention of cardioembolic stroke: standards and abnormal situations
, 2014 A. V. Fonyakin +1 more
openalex +2 more sources
Simple and rapid assay for effect of the new oral anticoagulant (NOAC) rivaroxaban: preliminary results support further tests with all NOACs [PDF]
, 2014 Raúl Altman, Claudio González
openalex +1 more source
Failure of oral anti-Xa to prevent non-bacterial thrombotic endocarditis in cancer: case report and literature review. [PDF]
Eur Heart J Case RepBenjelloun M +4 more
europepmc +1 more source
UEG Week 2025 Poster Presentations
United European Gastroenterology Journal, Volume 13, Issue S8, Page S803-S1476, October 2025.
wiley +1 more source